Reata Pharmaceuticals, Inc. EBITDA 2016-2023 | RETA
Reata Pharmaceuticals, Inc. ebitda from 2016 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Reata Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-280 |
| 2021 | $-237 |
| 2020 | $-218 |
| 2019 | $-283 |
| 2018 | $-76 |
| 2017 | $-46 |
| 2016 | $-6 |
| 2015 | $1 |
| 2014 | $6 |
| Reata Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-06-30 | $-95 |
| 2023-03-31 | $-112 |
| 2022-12-31 | $-81 |
| 2022-09-30 | $-71 |
| 2022-06-30 | $-64 |
| 2022-03-31 | $-64 |
| 2021-12-31 | $-70 |
| 2021-09-30 | $-56 |
| 2021-06-30 | $-58 |
| 2021-03-31 | $-53 |
| 2020-12-31 | $-52 |
| 2020-09-30 | $-52 |
| 2020-06-30 | $-47 |
| 2020-03-31 | $-67 |
| 2019-12-31 | $-184 |
| 2019-09-30 | $-38 |
| 2019-06-30 | $-33 |
| 2019-03-31 | $-28 |
| 2018-12-31 | $-24 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-26 |
| 2018-03-31 | $4 |
| 2017-12-31 | $-16 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-11 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-0 |
| 2015-12-31 | $-0 |
| 2015-09-30 | $1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $1 |
